Abstract With limited funding and biological specimen availability, choosing an optimal sampling design to maximize power for detecting gene-by-environment (G-E) interactions is critical. Exposure-enriched sampling is often used to select subjects with rare exposures for genotyping to enhance power for tests of G-E effects. However, exposure misclassification (MC) combined with biased sampling can affect characteristics of tests for G-E interaction and joint tests for marginal association and G-E interaction. Here, we characterize the impact of exposurebiased sampling under conditions of perfect exposure information and exposure MC on properties of several methods for conducting inference. We assess the Type I error, power, bias, and mean squared error properties of case-only, case-control, and empirical Bayes methods for testing/estimating G-E interaction and a joint test for marginal G (or E) effect and G-E interaction across three biased sampling schemes. Properties are evaluated via empirical simulation studies. With perfect exposure information, exposure-enriched sampling schemes enhance power as compared to random selection of subjects irrespective of exposure prevalence but yield bias in estimation of the G-E interaction and marginal E parameters. Exposure MC modifies the relative performance of sampling designs when compared to the case of perfect exposure information. Those conducting G-E interaction studies should be aware of exposure MC properties and the prevalence of exposure when choosing an ideal sampling scheme and method for characterizing G-E interactions and joint effects.
MA e
Marginal environmental association OR ge Odds ratio for the association between the genetic and environmental variables in controls b g Main effect log-odds ratio associated with the genetic factor OR g Exp(b g ) b e
Main effect log-odds ratio associated with the environmental factor OR e Exp(b e ) b g9e
Gene by environment interaction log-odds ratio OR g9e Exp(b g9e )
Background
Elucidating the role of interactions between genes and the environment in complex disease etiology has become a recent focus of many epidemiologic investigations [1, 2] . This expansion upon traditional genetic association studies that examine the relation between genetic variants and disease status is driven both by biological interest in the interplay between these genetic and environmental risk factors and by the potential increase in power that interactions may offer for detecting the existence of any genetic effect [3, 4] . Further, joint tests for marginal environmental and gene-environment (G 9 E) interaction effects may be helpful for identifying genetic subgroups among which the effects of environmental exposures are enhanced. Several approaches for estimating/testing for multiplicative G 9 E interaction have been proposed in the literature; the caseonly (CO), case-control (CC), and empirical Bayes (EB) methods have been widely used in the post genome-wide association study (GWAS) era [5] [6] [7] [8] _ENREF_1_EN-REF_1. The CO and EB approaches capitalize on geneenvironment independence to improve power to detect gene-environment interaction, with the EB approach achieving this goal in a more robust, data-adaptive manner.
Despite the potential for G 9 E interaction studies to unravel clues about the multi-factorial etiology of a complex disease, a significant obstacle in conducting a successful study lies in achieving enough power to detect potentially modest effect sizes. Thus, during the design stage, practical considerations including the optimization of constrained financial and biological sample resources remain a strategic challenge. While a power-maximizing sampling scheme for selecting GWAS subjects from specific exposure risk groups has been described for testing marginal association of the genes with disease, this approach is valid only when a lack of strong G 9 E interaction can be assumed [9] . When the goal of the study is actually to detect an interaction, some have proposed that leveraging environmental exposure information during sample selection for genotyping provides power advantages [10] . Exposure-enriched sampling designs may increase power by allowing for the oversampling of subjects from relatively rare exposure categories. However, the benefits of exposure-biased sampling designs for G 9 E interaction detection have not been rigorously evaluated. Further, it is known that non-differential misclassification (MC) of environmental exposure data can lead to biased estimates of interaction effects and can affect the power and type I error properties of statistical tests for interaction [11] [12] [13] [14] _ENREF_9. In addition, because differences in exposure recall between cases and controls are frequently noted, differential MC of exposure by disease status poses more severe of a concern for bias in estimation and inflated type 1 error as well as reduced power for statistical testing [13, 15, 16] . It remains unclear how either form of MC impacts the relative performance of different exposure enrichment designs implemented during the sampling phase, as the sampling strategy is now based on a contaminated exposure instead of a perfect exposure.
This report presents the results from a simulation study that examines the statistical advantages and disadvantages of various exposure-enriched sampling schemes for detecting G 9 E interactions and joint tests of both marginal and interaction effects. In addition, we aim to describe how exposure MC impacts the choice of such designs. Our focus here is to examine the influence that study design and sample selection decisions have on power/type 1 error for testing and efficiency/bias in estimation, with the goal of informing future analytic approaches.
It is true that the literature on two-phase or biased sampling design is now rich and methods for appropriately handling such data for inference about effects of the exposure are readily available (particularly in the absence of MC) [17] [18] [19] . For instance, a simple offset term using known sampling fractions for cases and controls can be derived to separate the effect of exposure under a biased sampling scheme from the actual effect of exposure under a logistic regression for CC studies. The various estimators considered in this paper can likewise be modified to appropriately account for the biased sampling design. Thus, a relevant analytic issue here would be to obtain an optimal design using the corrected estimators/tests that fully account for the biased sampling scheme. However, we do not adopt that strategy and simply illustrate the consequences of what is typically done in testing for genetic effects in large GWA studies where the design is optimized to enhance power for discovery (rightfully so, as the interest lies in detection of susceptibility loci and not estimating the true effect size very precisely) and standard analytic tools without finer adjustments for biased sampling are used. The effect of MC on such a design and analysis strategy is not present in the literature. Two sources of potential bias, exposure-enriched sampling and MC of exposure, are explored simultaneously in this study, adding new knowledge to the existing literature.
Methods
Simulation design: generation of the 2 9 4 table
We consider the analysis of simulated data generated from an unmatched CC study with a binary genetic factor (G), assuming a dominant genetic model, and a binary environmental variable (E). G takes a value of 1 for a genetically susceptible subject and 0 for a subject without a copy of the risk allele. For power comparisons, binary G is a reasonable assumption to consider because dichotomization maintains the relative performance of the methods and sampling designs expected from the more general codominant or additive scenario. In terms of exposure, E = 1 signifies exposed, and E = 0 designates unexposed subjects. Similarly, D represents disease status, where D = 1 indicates affected, and D = 0 denotes unaffected. Table 1 describes the distribution of cell counts in the underlying CC study base. Using the notations in Table 1 , the vectors of cell frequencies for cases and controls are realizations from two independent multinomial distributions, r 1 * Multinomialðn 1 ; p 11 ; p 12 ; p 13 ; p 14 Þ and r 0 * Multinomial ðn 0 ; p 01 ; p 02 ; p 03 ; p 04 Þ, respectively. OR 11 ¼ ðp 01 p 14 Þ= ðp 04 p 11 Þ denotes the odds ratio for individuals with G = 1 and E = 1 in relation to those baseline subjects with G = 0 and E = 0. OR 01 ¼ ðp 01 p 13 Þ=ðp 03 p 11 Þ signifies the D-G odds ratio among the unexposed, capturing the main effect of G, and OR 10 ¼ ðp 01 p 12 Þ=ðp 02 p 11 Þ represents the D-E association among the genetically non-susceptible, capturing the main effect of E. The multiplicative interaction parameter under study is represented by OR 11 =OR 10 OR 01 . We generate the control frequency vector first using given values of the prevalence of G, prevalence of E and odds ratio of gene-environment association in controls, namely OR ge . Using the control probability vector and given values of the main effect and interaction parameters, the case frequency vector is then generated [7] .
Tests for G 9 E interaction The three tests for G 9 E interaction employed here have been thoroughly described in the literature. In brief, we utilize the CC approach leveraging simple logistic regression, maximum likelihood estimation, and a standard Wald test for the null hypothesis of b g9e = 0. In addition, we conduct a CO analysis using a retrospective likelihood-based test that requires an assumption of gene-environment (G-E) independence. Finally, we employ the EB method which provides a trade-off between bias and efficiency of the previous two approaches (CC and CO) using a shrinkage estimator with adaptive weights attached to the CC and CO estimators. The adaptive weights for the EB estimator are identical to the one proposed in [7] , with more weight towards CC if geneenvironment independence is violated. Thus, the EB estimator is less susceptible to bias and Type 1 error than a CO estimator if there is gene-environment dependence.
Joint test for marginal genetic (or environmental) association and G 9 E interaction We employ the recently published approach that combines the use of two models (1 and 2 below) to jointly test the marginal effect of G (or E) and the G 9 E interaction [3] . The key differences between this method and a two degrees of freedom (df) likelihood ratio test for H 0 : [4] are that this approach tests for the marginal association of G (or E), as in (1), rather than the main effect in a full G 9 E model (2) , and for the interaction component it takes advantage of possible G-E independence when testing for G 9 E interaction through extension to the CO and EB approaches [3] . Let us consider the two models that yield the components of the joint tests that are considered in [3] :
The composite hypothesis being tested for G is H 0 : a g ¼ 0 and H 0 : b gÂe ¼ 0; and the composite hypothesis for E is H 0 : a e ¼ 0 and H 0 : b gÂe ¼ 0. Now, b g9e can be estimated using any of the three methods described above (CC, CO, or EB). The Wald v 2 test statistics for the marginal association tests in (1) and interaction tests in (2) are independent [3] . Thus, adding the two test statistics yields a 2 df v 2 test statistic of one of the following three forms (depending on which test is used for the interaction part: CC, CO or EB): We will study effect of exposure-biased designs in conjunction with potential MC on these three analytical strategies. Recall that CC does not use G-E independence, CO assumes it to be true, and EB adaptively uses it without making a blanket assumption like CO.
Exposure-enriched sampling designs
Following generation of data for the underlying CC study base, we consider three alternative sub-sampling schemes with differential enrichment for exposed subjects. As the genotyping budget is often limited, we assume a hypothetical scenario that resources are available to obtain genetic data on only half of the cases and controls in the original study base.
• Scheme 1 Select 50 % of cases and 50 % of controls from the full 2 9 4 table, preferentially including all exposed subjects (both cases and controls) and a random sample of unexposed subjects to reach the genotyping capacity. Since same rate of exposure enrichment is assumed for cases and controls, this design will not generate significant bias for exposure effect estimates, in spite of exposure enrichment.
• Scheme 2 Genotype 50 % of cases and 50 % of controls, including all exposed cases, a fixed percentage of exposed controls (50, 70, or 90 %), and a random sample of unexposed individuals to reach the genotyping capacity. Note that differential sampling rates across cases and controls will generate bias in the estimate of the exposure main effect as well as G 9 E interaction term.
• Scheme 3 Randomly sample 50 % of cases and 50 % of controls for genotyping irrespective of their exposure status. This scheme represents the traditional sampling design with no exposure enrichment but may lack power for testing G 9 E interaction.
Simulation settings
The base case simulates 5,000 cases and 5,000 controls as the underlying CC study base, from which a subsample of 2,500 cases and 2,500 controls are drawn for genotyping and inclusion in the G 9 E interaction study. We assume that the prevalence of exposure (P(E)) is 0.1 (relatively rare) and that the risk allele frequency for G (a single marker) is relatively common at 0.2. The true interaction odds ratio parameter (OR g9e ) is varied from the null value of 1.0 up to 1.8. Further, for this base case we assume that G-E independence holds and that perfect exposure information is available. The main effect of G (OR 01 = OR g = exp(b g )) and the main effect of E (OR 10 = OR e = exp(b e )) are both set to 1. We examine the relative performance of the G 9 E and joint effect detection methods under each sampling design with respect to power (the probability of rejecting the null hypothesis), type I error, mean squared error (MSE), and bias in parameter estimation. Biases are calculated with respect to deviation from the true marginal effects a g , a e , and the interaction effect b g9e . The reported results are based on 5,000 simulated datasets. Subsequently, the following sensitivity analyses are conducted for the perfect exposure measurement scenario by deviating from the base case. We vary the sample size of the underlying original study base down to 2,000 cases and 2,000 controls, the prevalence of exposure up to 0.3, OR g up to 1.3, and OR e up to 1.5. Also, we examine the impact of G-E independence violations by varying the G-E association parameter, OR ge , from 1.0 down to 0.8 and up to 1.1 (Supplementary Material).
Exposure misclassification (MC)
While we first test the three sampling schemes under the assumption of perfect exposure information, we then examine the impact of exposure MC on the performance of these designs. When MC is considered, the underlying study sample is generated in exactly the same way as described above and includes 5,000 cases and 5,000 controls. The true exposure (E) is generated first, followed by the contaminated exposure (E) based on the following probabilities associated with exposure measurement error:
Note that this generates non-differential MC because we do not consider disease status in the MC model. Then, with a sub-sampling rate of 50 % (i.e. 50 % of cases and 50 % of controls are selected for each sampling scheme), the final number of genotyped samples is 2,500 cases and 2,500 controls. Nine combinations of SE and SP parameters are assessed, with individual values ranging from 0.6 to 1.0. Because disease diagnosis may increase sensitivity and reduce specificity of recalling exposure history in cases as compared to controls, we also consider a situation of differential MC, where SE = 1.0 and SP = 0.6 among cases and SE = 0.8 and SP = 0.8 among controls [16] . Subsequently, the enriched sampling designs based on the observed misclassified exposures are employed, followed by interaction and joint effect testing as before.
Results

Exposure-biased sampling with perfect exposure information
Overall, the base case with 2,500 cases and 2,500 controls sampled from among 5,000 cases and 5,000 controls, an exposure prevalence of 10 %, and G-E independence demonstrates that exposure-enriched sampling increases power but yields bias in estimation of the interaction OR and the marginal effects of G and E ( Fig. 1 ; Supplementary Table 1) . Below, results for each of the proposed sampling schemes are presented individually, followed by a direct comparison of the designs.
Scheme 1
Scheme 1, with all exposed cases and controls genotyped as well as a random sample of unexposed subjects, performs quite well with respect to power across the CC, CO, and EB methods when testing only for the interaction as well as joint tests (Fig. 1) . Over 80 % power can be achieved by using one of the three interaction detection methods described for the OR g9e , joint MA g ? OR g9e , and Power (MAe + ORgxe) Fig . 1 Power comparison of three exposure-biased sampling designs under the base case with perfect exposure measurement. Each row represents one of three tests: G 9 E interaction (OR g9e ), joint marginal G and G 9 E interaction (MA g ? OR g9e ), or joint marginal E and G 9 E interaction (MA e ? OR g9e ). Each column designates one of three different approaches for OR g9e (CC case-control, CO case-only, EB empirical Bayes). Based on 5,000 simulated datasets, 2,500 cases and 2,500 controls, genotype information on one marker, OR g = OR e = 1, an exposed control subsampling rate of 0.5 for Scheme 2, and gene-environment independence. Scheme 1: genotype 50 % of cases and 50 % of controls including all E = 1 and a random sample of E = 0. Scheme 2: genotype 50 % of cases and 50 % of controls including all exposed cases, 50 % of exposed controls, and a random sample of E = 0. Scheme 3: randomly sample 50 % of cases and 50 % of controls for genotyping, irrespective of exposure status Table 1 ).
Scheme 2
In Scheme 2, 50 % of 5,000 cases and 50 % of 5,000 controls are genotyped according to the following distribution: all exposed cases, a predefined percentage of exposed controls, and a random sample of all unexposed subjects to fill the remaining samples. Scheme 2 performs increasingly similar to Scheme 1 as the proportion of exposed control samples selected for genotyping increases. Thus, only the lowest proportion of 0.5 that was considered is discussed below. When the sampling proportion of exposed controls is set to 0.5, power for detecting the interaction OR and joint effect of G across the range of OR g9e values considered is adequate, with the CO method yielding the greatest power at the lowest effect size among the three approaches (Fig. 1 ). This scheme is always able to detect a marginal effect of E due to the sampling design, even under the null hypothesis of H 0 : a e ¼ 0 and H 0 : b gÂe ¼ 0. Type I error for the OR g9e and joint effect of G tests are well-controlled under this scheme, hovering around the 0.05 level. Bias in OR g9e measurement is essentially nonexistent, but bias in MA g measurement is present at a modest level, and the well-anticipated downward bias for MA e is quite substantial (Supplementary Table 1 ).
Scheme 3
Scheme 3 randomly samples 50 % of cases and 50 % of controls, irrespective of exposure status. This scheme yields the lowest power for the interaction and joint tests as compared to the other two designs, not achieving 80 % power by at least one of the CC, CO, or EB methods until the true interaction OR reaches 1.6 (Fig. 1) . Again, the CO approach is the most powerful method employed in all three OR g9e and joint tests. Type I error is steadfast near 0.05 across all tests and detection methods. This scenario remains unbiased for detecting the interaction effect and the marginal effects of G and E as expected (Supplementary Table 1 ).
Sampling design comparison
In the settings for this scenario with G-E independence being true, CO analysis is unbiased under random sampling of cases and perfect exposure data. Thus, any source of bias for this G 9 E detection method can be directly attributed to the exposure-enriched sampling scheme. Scheme 1 performs consistently the best with respect to power across all three methods for the OR g9e and joint G tests (Fig. 1) . Also, Scheme 1 yields low bias in estimating OR g9e because the sampling fraction is the same for cases and controls. However, it does yield slightly greater bias in estimation of the MA g , and MA e parameters as compared to Scheme 3, which employs completely random sampling. MSE is low for OR g9e , MA g , and MA e and comparable across all three sampling designs (Supplementary Table 1 ).
While Scheme 2 appears to yield the greatest power for detecting the joint effect of E, this result is potentially driven by Type I error. Across all scenarios in the base case, the CO approach is the most powerful for detecting OR g9e . When the main effect of G is increased to 1.3, power for detecting the interaction OR and the joint effect of E increases marginally across all designs. However, as expected, power for detecting the joint effect of MA g plus the interaction OR g9e increases dramatically. Similarly, when the main effect of E (OR e ) is increased to 1.5, power for detecting OR g9e and the joint effect of G experience minimal boosts across all schemes but the detection rates of E effect increase substantially. Alternative settings were explored to examine the impact of different parameter values on power and bias as compared to the base case. If the prevalence of exposure is increased to 30 %, there is very little separation between the three sampling schemes with respect to power or bias for the interaction or joint tests (Supplementary Table 2 ). The CO approach remains the most powerful when the G-E independence assumption still holds, and the relative performance of the three sampling schemes remains the same. When the sample size is decreased to 2,000 cases and 2,000 controls (prior to genotyping 50 % of the subjects), there is an overall depression of power across all three methods, and the differential across sampling schemes is exacerbated (Supplementary Table 3) . G-E dependence yields greater bias in estimation of OR g9e for CO and EB approaches but does not affect the relative performance of the three exposure-enriched sampling designs with respect to power (Supplementary Tables 4, 5) . The CO approach suffers the most, but this phenomenon under violation of G-E independence has been well-characterized in the literature.
Exposure-biased sampling based on misclassified exposure information
The same exposure-biased sampling schemes were reexamined under the scenario of imperfect exposure information across a range of SE and SP values. Here, the base case includes 5,000 cases and 5,000 controls with prevalence of exposure set to 10 %, OR g = OR e = 1, and scheme 2 sub-sampling rate of exposed control subjects set to 50 %. We present results for non-differential MC in detail, followed by a brief commentary on the relative performance of sampling designs when exposure MC is differential by disease status.
Scheme 1
This design with the strongest exposure-enriched sampling experiences a severe depression in power for detecting GxE interaction across the CC, CO, and EB methods, especially for the anticipated modest effect sizes (Supplementary Table 6 ). As expected, at each combination of SE and SP, power increases as the true OR g9e increases (Supplementary Table 7 ). The CO approach is the most powerful at all combinations of SE and SP, but it achieves only 68 % power with SE and SP of 0.8 when the true interaction OR is 1.8. For this same effect size and SE-SP configuration, CC only has power of 40 %, and it is only when SE C0.6 and SP = 1 that CC achieves power[90 %. The EB approach yields intermediate power results that reflect its hybrid nature between the CO and CC methods. A decrease in SP depresses power to a greater extent than an identical decrease in SE. Power for the joint test of a marginal effect of G (or E) and the GxE interaction on disease status is also negatively impacted by MC but is affected to a slightly lesser extent than the interaction-only test. Type I error is tightly controlled for all three methods of detecting G 9 E interaction across the range of sensitivities, specificities, and true OR g9e values. This is to be expected as SP and SE do not make an impact under the null hypothesis under this MC scheme.
Supplementary Table 7 also demonstrates that the reduction of SE and SP leads to increasingly biased estimates of OR g9e and the marginal effect of E (MA e ; the marginal effect of G, MA g , is minimally biased). Type I error for both joint tests is 0.05 or below across all SE, SP, and true OR g9e ranges.
Scheme 2
Scheme 2 also experiences a decrease in power for detecting the stand-alone GxE interaction and the joint effect of G plus G 9 E interaction in the presence of exposure MC (Supplementary Table 8 ). For the interaction effect, the CO analysis still performs best in the base case, and the CC and EB approaches are influenced to a greater extent by the MC. Power for detecting the joint effect of G and G 9 E is less affected by a decrease in SE than SP. Type I error is reasonably controlled for the OR g9e test even at low SP and SE combinations but becomes slightly inflated for the joint test for G across all three methods. The joint test for E in this design is dominated by sampling bias reflected in type I error. The reduction of SE and SP leads to more positively biased estimates of OR g9e and extreme negatively biased estimates of MA e ; again, the estimate of MA g is mostly unaffected.
Scheme 3
This design which is blind to exposure status also suffers in terms of power when SP and SE of exposure measurement drop below one (Supplementary Table 9 ). The test for interaction is severely impacted, to a greater extent than either of the joint tests for a given combination of SE and SP. The power achieved for detecting a true interaction parameter of 1.8 is a maximum of 0.58 when SE = SP = 0.8 and all three of the CC, CO, and EB approaches are considered (Supplementary Table 9 ). This scheme yields very tightly controlled type 1 error for the interaction and joint G (or E) tests across all three methods for detecting OR g9e . Bias in OR g9e estimation increases rapidly as SP of exposure measurement drops. There is no bias in MA g estimation, but there exists modest bias in MA e , particularly as SE and SP approach 0.6 and the true interaction parameter nears 2.0.
Sampling design comparison
As SP and SE decrease, power decreases across all three tests and methods for OR g9e detection for all three sampling designs (Supplementary Tables 7-9 ). Figure 2 visually summarizes the power comparison across sampling designs when SP and SE are both set to 0.8 (Supplementary Table 6 ). The apparent benefit of Scheme 1 that was demonstrated in the presence of perfect exposure information does not carry over when exposure is misclassified. There is no uniformly most powerful design across the range of true interaction parameter values for the interaction-only test (Fig. 3) . For detecting OR g9e , Scheme 1 overtakes Scheme 2 as the most powerful around a true OR of 1.4. Scheme 2 performs marginally better than the other two designs across the range of true values below 1.4 down to 1.0. For the joint effect of G, Scheme 2 outperforms Scheme 1 with respect to power at more modest true OR g9e levels. Interestingly, for all three scenarios, the joint test for G is not always more powerful than the marginal test for G. Among the values examined, the joint test for G is more powerful than the marginal test for G only when SP C0.8 and SE C0.6 (Schemes 1, 2) and when SP C0.6 and SE C0.8 (Scheme 3). While Scheme 2 also appears to yield the greatest power for detecting the joint effect of E, this result is likely driven by Type I error. Ignoring Scheme 2, Scheme 1 achieves higher power than Scheme 3 regardless of the OR g9e detection method chosen. Across all scenarios in the base case, the CO approach Detection of gene-environment interactions 419
has the potential to achieve the most power for detecting OR g9e and the joint effect of G (or E). Again focusing on the scenario where SE = SP = 0.8, type I error is tightly controlled for all tests when employing Schemes 1 or 3, with slight inflation for Scheme 1's joint test for E (Supplementary Table 6 ). Type I error is marginally inflated for the joint G test and drastically inflated for the joint E test when Scheme 2 sampling is conducted (Supplementary Table 6 ). Decreasing SP introduces a large bias in OR g9e estimation across all three schemes (Supplementary Tables 7-9 ). However, the bias in MA e is more substantial for Scheme 2 than for either or Schemes 1 or 3, which demonstrated relatively comparable bias in estimation of this parameter. There is minimal bias in MA g estimation in Schemes 1 and 2 and none for Scheme 3. Like the scenario of perfect exposure information, MSE for MA g and MA e estimation is minimal across all three sampling designs. However, MSE for OR g9e is quite severely penalized as SP and SE drop. The impact of gene-environment independence violations on the above observations can be visualized in Supplementary Figures 1  (OR Power (MAe + ORgxe) Fig . 2 Power comparison of three exposure-biased sampling designs under the base case with exposure misclassification (sensitivity = 0.8; specificity = 0.8). Each row represents one of three tests: G 9 E interaction (OR g9e ), joint marginal G and G 9 E interaction (MA g ? OR g9e ), or joint marginal E and G 9 E interaction (MA e ? OR g9e ). Each column designates one of three different approaches for estimating the G 9 E interaction parameter (CC casecontrol, CO case-only, EB empirical Bayes). Based on 5,000 simulated datasets, 2,500 cases and 2,500 controls, genotype information on 1 marker, OR g = OR e = 1, an exposed control subsampling rate of 0.5 for Scheme 2, and gene-environment independence. Scheme 1: genotype 50 % of cases and 50 % of controls including all E = 1 and a random sample of E = 0. Scheme 2: genotype 50 % of cases and 50 % of controls including all exposed cases, 50 % of exposed controls, and a random sample of E = 0. Scheme 3: randomly sample 50 % of cases and 50 % of controls for genotyping, irrespective of exposure status case with differential MC (SE case = 1.0; SP case = 0.6; SE control = SP control = 0.8) shows a loss of Scheme 1's power advantage. Scheme 3 now performs best with respect to power for detecting the interaction-only effect.
For the joint effect of G, Schemes 1 and 2 achieve comparable power across the range of OR g9e parameters considered. Type I error remains tightly controlled for all sampling designs across all tests except for the joint test for E. Bias in OR g9e estimation is slightly more severe than in the case of non-differential MC, but the levels of bias are still comparable across sampling designs. The bias in MA e is substantially greater for differential as compared to nondifferential MC, but Scheme 2 remains the sampling design with the most bias. If G-E independence is violated (OR ge = 0.8) in addition to differential MC, the relative performance of sampling schemes remains the same as when OR ge = 1.0.
Discussion
This simulation study characterizes the benefits and limitations of various exposure-enriched sampling designs for detecting G 9 E interactions or joint genetic (or environmental) effects in unmatched CC studies. It also considers biased sampling in the context of exposure MC. In the absence of exposure MC, a design that samples all exposed individuals (Scheme 1) is an optimal approach with respect to power maximization while yielding tolerable levels of bias in estimation for both the interaction parameter and marginal G (or E) effects. Further, type I error is controlled under this enriched sampling scheme. In addition to the test for pure GxE interaction which has been studied in the past, we characterize the impact of different exposurebiased sampling designs on simultaneous testing when both a marginal genetic (or environmental) effect and G-E interaction are of interest. These joint tests are particularly useful in that they may increase power for detecting the presence of a genetic (or environmental) effect in the presence of G 9 E interaction. With perfect exposure information, an exposure-enriched sampling design further enhances the power for detecting the joint effect of G in presence of non-null interaction.
It is important to recognize that these advantages of exposure-enriched sampling and the comparison between sampling designs do not hold uniformly under all conditions that vary from the base case. First, the power advantages are accentuated when the exposure is relatively rare. When the environmental factor is more common, exposure-biased sampling designs become less distinguishable from random sampling. Further, exposure MC is a common problem plaguing epidemiologic studies. Thus, we sought to address this practical limitation by examining the impact of exposure MC on the relative performance of the three sampling designs. Although Scheme 1 is ideal under perfect exposure measurement conditions, in the situation of imperfect information, we demonstrate that no single exposure-biased sampling scheme is consistently the optimal design. The preferred approach in terms of power depends on the strength of the anticipated interaction OR, which method of OR g9e detection is used (CC, CO, or EB), whether interest is in the interaction itself or in boosting power to detect any genetic effect that exists (an emphasis on the joint test for G and G 9 E interaction), and whether MC is differential or non-differential.
Although power is a key concern for G 9 E interaction studies, bias in parameter estimation is another important element when evaluating these statistical methods. Fig . 3 Sampling scheme preference with respect to power maximization across different specificity (SP) and sensitivity (SE) combinations. The empirical Bayes method was used to estimate OR g9e . Based on 5,000 simulated datasets, 2,500 cases and 2,500 controls, genotype information on one marker, gene-environment independence, OR g = OR e = 1.0, and an exposed control subsampling rate of 0.5 for Scheme 2. Scheme 1: genotype 50 % of cases and 50 % of controls including all E = 1 and a random sample of E = 0. Scheme 2: genotype 50 % of cases and 50 % of controls including all exposed cases, 50 % of exposed controls, and a random sample of E = 0. Scheme 3: randomly sample 50 % of cases and 50 % of controls for genotyping, irrespective of exposure status
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Previous work has shown that differential exposure MC by disease status does not lead to bias in OR g9e estimation when a multiplicative interaction truly exists if exposure SE and SP measures are non-differential by genotype and G-E independence is present among controls [13] . We show here that bias in estimating the OR g9e parameter does not exist in the presence of exposure-enriched sampling when exposure information is perfect. However, in the situation of exposure MC (differential and non-differential), bias in OR g9e estimation appears across all sampling designs as the true interaction OR increases. With respect to marginal effect estimation, there is substantial bias for MA e without exposure MC for the design with unequal proportions of exposed cases and controls (Scheme 2) and for all three designs when exposure MC occurs. Thus, investigators conducting G 9 E interaction studies who are considering an exposure-enriched sampling scheme should be cognizant of this potential increase in bias when exposure is difficult to measure accurately. MC is a wellacknowledged problem that is not often considered seriously in the design stage. This study has several limitations that could be addressed in future work. First, this analysis focuses on a single genetic marker. Often, G 9 E interaction studies are conducted in the context of post-GWAS analyses, where a multitude of candidate markers are of interest. As multiple testing rapidly increases, the power simulated in this study becomes severely penalized. However, even for a single marker, it would be interesting to consider if other genetic models or rarer genetic variation make any impact on the relative performance of different sampling schemes. In addition, we do not consider here the MC of G in addition to imperfect exposure information. This MC is possible given that genotyping arrays have associated error rates, and other studies have considered the impact of such errors [20, 21] . Further studies may investigate in greater depth the influence of both G and E MC on the relative performance of different sampling designs. Also, we consider only a binary environmental exposure, but many such exposures are ordinal or continuous in practice. Furthermore, our focus here is on CC studies, but it would be useful to examine the impact of exposure-biased sampling on other types of study designs.
Although we demonstrate that exposure MC distorts the benefit of using an exposure-biased design, the investigator is typically unaware of the extent to which an epidemiologically-assessed environmental exposure is misclassified. This makes it difficult to differentiate if Scheme 1 will have clear advantages. One solution may be to estimate the SE and SP of exposure measurement using a validation sub-study [22, 23] _ENREF_10_ENREF_10. However, even if no validation sample exists to estimate SE and SP, we have demonstrated that knowledge of a range for the SP and SE parameters can assist in choosing the optimal sampling design for that range. When considering the maximization of power, Scheme 2 has benefits over Scheme 1 under the scenario of modest non-differential exposure MC when anticipated effect sizes are low. On the other hand, Scheme 3 remains consistently unbiased but can severely lack power with perfect exposure. However, contrary to expectations, Scheme 3 has the power advantage when exposure MC is differential by disease status. In addition, some have proposed that correction for the effect of exposure MC is possible [23] [24] [25] . Some have presented solutions to handle measurement errors in environmental factors under genome-wide G 9 E interaction scans. Lobach et al. [26] proposed a pseudo-likelihood model in which the environmental covariate is non-parametrically modeled and its dependence on disease-status is also considered. Alternatively, Lobach et al. [27] have illustrated a semi-parametric Bayesian approach where the potentially skewed inferences on the risk parameters due to measurement errors are handled through the symmetric normality prior on the risk parameter. While not a replacement for better exposure measurement, it would be worthwhile to learn if these correction methods restore the advantages of exposure-biased sampling that are visible with perfect exposure information.
Overall, results from this study provide rigorous support for a method of prioritizing subjects for genotyping. Overall, exposure enrichment appears to be a beneficial strategy for maximizing available resources for G 9 E interaction detection under the scenario of perfect exposure information. Genetic epidemiology studies are expensive to design and implement, so this strategy that boosts power on a fixed budget is quite advantageous. However, those conducting G 9 E studies should be careful to consider exposure measurement MC properties and the prevalence of exposure when choosing an ideal sampling scheme and method for GxE interaction detection. Finally, it is important to recognize that no matter how powerful the test, any G 9 E interactions that are identified require validation and replication, which has proven to be challenging due to differences in the distribution of both genetic and environmental exposure across populations.
